217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'

Can CRISPR edit out a heart attack? What happens on #GutTok? And is health care recession-proof? Sek Kathiresan, cardiologist and CEO of Verve Therapeutics, joins us to explain the company's work on preventing heart disease with genome editing. Then, STAT's Isabella Cueto joins us to discuss "Hot girls have IBS," an internet in-joke that evolved into a movement for people with chronic illness. We also break down the latest news in the life sciences, including a long-awaited victory for Novavax and ostensible good news for biotech.

Episode metadata supplied by the publisher feed · Published Jul 14, 2022

Embed this episode

Attribution link and audio player

Ready to play

217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'

0:00 30:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 30 minutes long.

When was this The Readout Loud episode published?

This episode was published on July 14, 2022.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!